Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592355 · ClinicalTrials.gov registry record · NA
Virtual Visits at Brigham and Women's Hospital
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT03592355 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 77 participants.
The verdict
NCT03592355, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm). The investigators plan to enroll no more than 200 clinicians. Any clinician in a department selected by the Brigham Health Virtual Care team for access to virtual visits is eligible, unless s/he saw less than 20 patients monthly over the last 6 months. The Brigham Health Virtual Care team will onboard all clinicians and provide virtual visit support as per their usual protocol. The primary study endpoint is third-available appointment, a well-adopted measure of access. Other secondary endpoints revolve around continuity, efficiency, utilization, safety, cost, and patient experience.
Interventions
- OTHER Virtual Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2018-04-13 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03592355
The ClinicalTrials.gov registry entry for NCT03592355 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual Visit is the first listed.
NCT03592355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03592355 about?
NCT03592355 is a clinical study titled "Virtual Visits at Brigham and Women's Hospital". Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm). The investigators plan to enroll no more than 200 clinicians. Any c...
What is the current status of trial NCT03592355?
This trial is currently terminated. It is a NA study. The enrollment target is 77 participants. The study started on 2018-04-13. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT03592355?
The interventions under investigation include: Virtual Visit (OTHER).
Who is sponsoring clinical trial NCT03592355?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.